John Maraganore, Chief Executive Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 69,428 shares at $123.55 ($8.6M) on 2020-11-19, disclosed to the SEC on 2020-11-20.
Open-market sale of $8.6M ALNY by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $123.55 | 18,987 | $2.3M | 27.2% |
| 2 | $123.55 | 18,987 | $2.3M | 27.2% |
| 3 | $124.49 | 5,489 | $683K | 7.9% |
| 4 | $124.49 | 5,489 | $683K | 7.9% |
| 5 | $125.35 | 10,187 | $1.3M | 14.8% |
| 6 | $125.35 | 10,187 |
| $1.3M |
| 14.8% |
| 7 | $126.62 | 102 | $13K | 0.1% |
| Total | $124.23 avg | 69,428 | $8.6M | 100% |
| Filing → |
| ALNY | SELL | 2021-05-17 | $8.9M | — | Filing → |
| ALNY | SELL | 2021-02-26 | $9.4M | — | Filing → |
| ALNY | SELL | 2020-08-21 | $9.5M | — | Filing → |